TF–FVIIa–driven PAR2 activation triggers EV generation from human TNBC cells, which promotes EMT in non–metastatic breast cancer cells, leading to the induction of proliferation, migration, invasion, and anti–apoptosis

TF–FVIIa–driven PAR2 activation triggers EV generation from human TNBC cells, which promotes EMT in non–metastatic breast cancer cells, leading to the induction of proliferation, migration, invasion, and anti–apoptosis. TF–FVIIa–mediated cleavage of PAR2 in human TNBC cells leads to the intracellular activation of AKT, ROCK, and ERK1/2 pathways independently, which promotes the release of EVs packaged with miR–221 via actomyosin reorganization. TNBC–EVs are taken up by non–metastatic breast cancer cells, thereby delivering miR–221 into the recipient cells. In recipient cells, miR–221 targets PTEN, leading to the activation of AKT/p65–signaling pathway in which the activated (via phosphorylation) p65 enters the nucleus to stimulate the upregulation of N–cadherin and vimentin while downregulating the expression of E–cadherin. As a result of this, EMT is induced, which ultimately leads to the promotion of proliferation, migration, invasion, and anti–apoptosis of EV–fused recipient cells. Red arrows indicate decreased and green arrow indicate increased levels.
TF–FVIIa–driven PAR2 activation triggers EV generation from human TNBC cells, which promotes EMT in non–metastatic breast cancer cells, leading to the induction of proliferation, migration, invasion, and anti–apoptosis

Publication

Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential (2023) Kaushik Das, et al. Cancers (Basel). 2023 Oct;15(19). Figure: F5.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates PAR2 PAR2 ncbigene_synonym F2RL1 2150
Homo sapiens Primates PAR2 PAR2 ncbigene_synonym NR1I2 8856
Homo sapiens Primates PAR2 PAR2 ncbigene_synonym SLC52A1 55065
Homo sapiens Primates ERK1 ERK1 ncbigene_synonym MAPK3 5595
Homo sapiens Primates ERK1/2 ERK2 ncbigene_synonym MAPK1 5594
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000
Homo sapiens Primates ROCK ROCK famplex_relations ROCK1 6093
Homo sapiens Primates ROCK ROCK famplex_relations ROCK2 9475
Homo sapiens Primates miR-221 MIR-221 ncbigene_synonym MIR221 407006
Homo sapiens Primates E-cadherin↓ CDH1 ncbigene_symbol CDH1 999
Homo sapiens Primates E-cadherin↓ CDH1 ncbigene_synonym FZR1 51343
Homo sapiens Primates P65 P65 ncbigene_synonym RELA 5970
Homo sapiens Primates P65 P65 ncbigene_synonym SYT1 6857
Homo sapiens Primates P65 P65 ncbigene_synonym GORASP1 64689
Homo sapiens Primates P65 P65 ncbigene_synonym WNK1 65125
Homo sapiens Primates N-cadherin CDH2 ncbigene_symbol CDH2 1000
Homo sapiens Primates EMT EMT ncbigene_synonym ITK 3702
Homo sapiens Primates EMT EMT ncbigene_synonym SLC22A3 6581
Homo sapiens Primates PTEN PTEN ncbigene_symbol PTEN 5728

Chemical mentions

Word Match MeSH Name ChEBI
Nucleus nucleus nucleus chebi:33252
Nucleus nucleus nucleus chebi:33252

Disease mentions

Word Match MeSH Name DOID
cancer cancer cancer DOID:162
breast cancer breast cancer breast cancer DOID:1612